QHSLab, Inc.
QHSLab, Inc. (USAQ) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
usaq · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for QHSLab, Inc. (USAQ) measures how much investors pay for each dollar of the company's trailing earnings. USAQ's current PE ratio of 12.15x is calculated by dividing its stock price of $0.35 by its TTM earnings per share of $0.03. −18.8% discount vs 5Y avg 15.0x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
QHSLab, Inc.You USAQ | $4M | 12.15x | — | $0.03 |
 Algernon Pharmaceuticals Inc. AGNPF | $2M | N/A | — | -$0.58 |
 Appili Therapeutics Inc. APLIF | $2M | N/A | — | -$0.02 |
 Caduceus Software Systems Corp. CSOC | $1M | N/A | — | -$0.01 |
 City View Green Holdings Inc. CVGRF | $1M | N/A | — | -$0.02 |
 Genix Pharmaceuticals Corporation GENPF | $1M | N/A | — | -$0.01 |
 Imagion Biosystems Limited IBXXF | $7M | N/A | — | -$0.02 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 14.96x | $0.04 | — | |
2024-12-31 FY2024 | — | $-0.03 | — | |
2023-12-31 FY2023 | — | $-0.05 | — | |
2022-12-31 FY2022 | — | $-0.11 | — | |
2021-12-31 FY2021 | — | $-0.10 | — | |
2020-12-31 FY2020 | — | $-0.05 | — | |
2019-12-31 FY2019 | — | $-0.03 | — | |
2018-12-31 FY2018 | — | $-0.01 | — | |
2017-12-31 FY2017 | — | $-0.00 | — | |
2016-12-31 FY2016 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for QHSLab, Inc. (USAQ) measures how much investors pay for each dollar of the company's trailing earnings. USAQ's current PE ratio of 12.15x is calculated by dividing its stock price of $0.35 by its TTM earnings per share of $0.03.
Frequently asked questions
USAQ pe ratio · 6 questionsUSAQ's current PE ratio is 12.15x as of 2026-06-15, based on a stock price of $0.35 and TTM EPS of $0.03. Data sourced from Financial Modeling Prep via USAQ's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · QHSLab, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15